Under the futures and options (F&O) segment, three stocks were banned from trade on Wednesday, August 2, by the National Stock Exchange (NSE). The securities
In the early opening hours on Wednesday, the GIFT Nifty futures were trading negatively, indicating an opening in the red for domestic indices. The benchmark
Lupin received approval from the US Food and Drug Administration for manufacturing and marketing Turqoz, a genetic equivalent of the pregnancy prevention pill Lo/Ovral-28. The
The Mumbai-based drug maker Glenmark Pharmaceuticals on 1 August said it had received the nod from the US Food and Drug Administration (USFDA) to market
On 1 August, Reliance Industries signed an MoU with Brookfield Asset Management to explore the opportunities to produce renewable energy and manufacturing decarbonisation equipment in